Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDZ domain-containing protein 11 (PDZD11) is a human protein encoded by the PDZD11 gene. It is a member of the PDZ domain family, acting primarily as an adaptor or scaffold protein. PDZD11 participates in protein-protein interactions at cell-cell junctions, facilitating the docking of ADAM10 to the zonula adherens by interacting with PLEKHA7, which enables PLEKHA7 to associate with the ADAM10-binding protein TSPAN33[2][8]. PDZD11 is involved in pore complex assembly and the regulation of calcium pump (PMCA) localization and calcium handling in cells[2][7][6]. PDZD11 interacts with several proteins, including ATP2B1-4 (plasma membrane calcium ATPases) and ATP7A[2]. While it plays important roles in protein localization and cell-cell junction integrity, there is currently no evidence that it is a direct therapeutic target, nor are there known interacting drugs or established clinical safety concerns. Its gene is located on the X chromosome[6]. Disease associations have been suggested with certain forms of otitis media[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDZ domain-containing protein 11 (PDZD11).